| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 2.93e-06 | 5 | 134 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.01e-05 | 7 | 134 | 3 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.01e-05 | 7 | 134 | 3 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 3.43e-05 | 10 | 134 | 3 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 3.43e-05 | 10 | 134 | 3 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 3.43e-05 | 10 | 134 | 3 | GO:0102033 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 4.47e-05 | 2 | 134 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 4.47e-05 | 2 | 134 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 8.05e-05 | 13 | 134 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 1.55e-04 | 16 | 134 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | acid-amino acid ligase activity | 4.74e-04 | 23 | 134 | 3 | GO:0016881 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 5.39e-04 | 24 | 134 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ANK3 SPTBN1 APC NLGN1 ITGB6 CEMIP2 MICALL1 CDH20 NLGN4X EHD1 TJP2 NLGN2 | 7.21e-04 | 599 | 134 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 7.68e-04 | 27 | 134 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.30e-03 | 120 | 134 | 5 | GO:0004222 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 5.17e-06 | 6 | 133 | 3 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 9.00e-06 | 7 | 133 | 3 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 1.43e-05 | 8 | 133 | 3 | GO:0036100 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 3.04e-05 | 10 | 133 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 4.16e-05 | 11 | 133 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 4.16e-05 | 11 | 133 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 5.53e-05 | 12 | 133 | 3 | GO:0042758 | |
| GeneOntologyBiologicalProcess | membrane assembly | 5.81e-05 | 64 | 133 | 5 | GO:0071709 | |
| GeneOntologyBiologicalProcess | nuclear migration | 6.59e-05 | 34 | 133 | 4 | GO:0007097 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 7.15e-05 | 13 | 133 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 1.09e-04 | 73 | 133 | 5 | GO:0044091 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 1.23e-04 | 3 | 133 | 2 | GO:0042361 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.38e-04 | 16 | 133 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | neuron development | CUL4B DDR1 ANK3 TRIO SYNE1 FAT3 APC TSC2 NLGN1 ZDHHC17 THOC2 TTC3 MICALL1 EHD1 DOCK7 PLXNA4 TAOK1 NLGN2 TRPM1 RP1 PAX6 EPHA5 | 1.64e-04 | 1463 | 133 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | nucleus localization | 1.84e-04 | 44 | 133 | 4 | GO:0051647 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | VHL DDR1 ANK3 TRIO SYNE1 FAT3 ANO1 APC TSC2 NLGN1 ZDHHC17 THOC2 TTC3 ITGB6 CDH20 DOCK7 PLXNA4 PAX6 EPHA5 | 2.38e-04 | 1194 | 133 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 2.46e-04 | 4 | 133 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 2.46e-04 | 4 | 133 | 2 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 2.46e-04 | 4 | 133 | 2 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 2.46e-04 | 4 | 133 | 2 | GO:0042377 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 2.46e-04 | 4 | 133 | 2 | GO:0009233 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, GABAergic | 2.76e-04 | 20 | 133 | 3 | GO:0032230 | |
| GeneOntologyBiologicalProcess | response to follicle-stimulating hormone | 3.20e-04 | 21 | 133 | 3 | GO:0032354 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 3.63e-04 | 204 | 133 | 7 | GO:0048592 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 3.69e-04 | 22 | 133 | 3 | GO:1901569 | |
| Domain | Nlgn | 3.26e-06 | 5 | 130 | 3 | IPR000460 | |
| Domain | P-loop_NTPase | KIF6 DDX17 VWA8 DHX40 ZGRF1 MCM7 AK9 PFKFB1 EFTUD2 NWD2 EHD1 TJP2 SRL MYH15 CHD6 KIF18B ATP5F1B | 8.30e-05 | 848 | 130 | 17 | IPR027417 |
| Domain | Carboxylesterase_B_CS | 8.96e-05 | 13 | 130 | 3 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.13e-04 | 14 | 130 | 3 | PS00941 | |
| Domain | COesterase | 1.13e-04 | 14 | 130 | 3 | PF00135 | |
| Domain | CarbesteraseB | 1.13e-04 | 14 | 130 | 3 | IPR002018 | |
| Domain | PH | 2.04e-04 | 229 | 130 | 8 | PF00169 | |
| Pathway | REACTOME_EICOSANOIDS | 8.65e-05 | 12 | 106 | 3 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 8.65e-05 | 12 | 106 | 3 | M27128 | |
| Pathway | REACTOME_EICOSANOIDS | 8.65e-05 | 12 | 106 | 3 | MM14845 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.04e-04 | 33 | 106 | 4 | M39875 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.42e-04 | 14 | 106 | 3 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.76e-04 | 15 | 106 | 3 | M27126 | |
| Pubmed | DDX17 ANK3 APC MCM7 CEMIP2 EFTUD2 RIF1 PPP2R3A SLC12A2 LMNB1 WDR11 EHD1 XRN1 DOCK7 TJP2 ZFR PCDH10 TASOR ARAP2 | 2.27e-10 | 777 | 136 | 19 | 35844135 | |
| Pubmed | TPR SIN3B ANK3 TRIO SYNE1 SPTBN1 HECTD4 APC TSC2 TTC3 RTN1 EFTUD2 LMNB1 DOCK7 ZFR NLGN2 CDC73 MAPK1 TP53BP2 | 7.64e-09 | 963 | 136 | 19 | 28671696 | |
| Pubmed | DCHS2 ANK3 TRIO SYNE1 SPTBN1 HECTD4 APC CTDSP1 TSC2 BRCC3 REV3L TTC3 TRIM59 TTLL12 CRNKL1 ADAMTS9 TAOK1 CHD6 PAX6 TRIM37 ATP5F1B | 3.03e-08 | 1285 | 136 | 21 | 35914814 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR TBRG4 DDX17 TRIO SYNE1 SPTBN1 PPIL4 MCM7 THOC2 TTC3 EFTUD2 TTLL12 CRNKL1 RIF1 LMNB1 GCLC UBTF DOCK7 ZFR CDC73 USP39 ATP5F1B | 3.73e-08 | 1425 | 136 | 22 | 30948266 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR DDX17 SYNE1 MCM7 THOC2 EFTUD2 CRNKL1 RIF1 SLC12A2 LMNB1 BBS7 UBTF DOCK7 TJP2 ZFR USP39 MAPK1 ATP5F1B | 1.11e-07 | 1024 | 136 | 18 | 24711643 |
| Pubmed | 1.71e-07 | 153 | 136 | 8 | 10718198 | ||
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 2.33e-07 | 4 | 136 | 3 | 18065749 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR DDX17 DHX40 SPTBN1 PPIL4 MCM7 EFTUD2 CRNKL1 RIF1 LMNB1 WDR11 UBTF UFD1 EHD1 XRN1 ZFR MAPK1 KIF18B TP53BP2 ATP5F1B | 3.32e-07 | 1353 | 136 | 20 | 29467282 |
| Pubmed | 3.86e-07 | 234 | 136 | 9 | 36243803 | ||
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 5.82e-07 | 5 | 136 | 3 | 15620359 | |
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 37865312 | ||
| Pubmed | Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development. | 5.82e-07 | 5 | 136 | 3 | 23358245 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 5.82e-07 | 5 | 136 | 3 | 10996085 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 6.41e-07 | 182 | 136 | 8 | 32239614 | |
| Pubmed | TPR SIN3B SATB2 ZGRF1 APC MCM7 XRN1 DOCK7 CHD6 TASOR TP53BP2 | 8.42e-07 | 418 | 136 | 11 | 34709266 | |
| Pubmed | Aire's partners in the molecular control of immunological tolerance. | 9.15e-07 | 45 | 136 | 5 | 20085707 | |
| Pubmed | Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly. | 1.03e-06 | 20 | 136 | 4 | 32294449 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 21838267 | ||
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 9068972 | ||
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 29724786 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CDC42BPG SIN3B MAGEE2 TSC2 REV3L TTLL12 CDH20 LMNB1 ADAMTS9 TBC1D14 PLXNA4 CHD6 USP39 PCDH10 | 1.26e-06 | 736 | 136 | 14 | 29676528 |
| Pubmed | CUL4B DDX17 SPTBN1 MCM7 THOC2 EFTUD2 TTLL12 CRNKL1 RIF1 LMNB1 CDC73 USP39 ATP5F1B | 1.45e-06 | 638 | 136 | 13 | 33239621 | |
| Pubmed | CUL4B TPR DDX17 SPTBN1 PPIL4 MCM7 EFTUD2 TTLL12 CRNKL1 LMNB1 UBTF ZFR ATP5F1B | 1.53e-06 | 641 | 136 | 13 | 36057605 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DDX17 FBLL1 DHX40 PPIL4 MCM7 THOC2 EFTUD2 RIF1 LMNB1 UBTF UFD1 ZFR CDC73 USP39 KIF18B ATP5F1B | 1.75e-06 | 989 | 136 | 16 | 36424410 |
| Pubmed | TPR SIN3B FBLL1 ANK3 MCM7 THOC2 LMNB1 XRN1 DOCK7 TJP2 ZFR TP53BP2 | 1.83e-06 | 549 | 136 | 12 | 38280479 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.65e-06 | 220 | 136 | 8 | 35785414 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 3.13e-06 | 26 | 136 | 4 | 34848499 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VHL SIN3B DDX17 BRCC3 THOC2 SQOR EFTUD2 RIF1 LMNB1 UBTF ZFR CHD6 CDC73 PAX6 USP39 KIF18B TASOR ATP5F1B | 3.19e-06 | 1294 | 136 | 18 | 30804502 |
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 16129783 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 3.23e-06 | 8 | 136 | 3 | 30871858 | |
| Pubmed | TPR ANK3 SYNE1 SPTBN1 APC PLEKHA6 ZDHHC17 RIF1 ARHGAP31 CHD6 MAPK1 | 3.60e-06 | 486 | 136 | 11 | 20936779 | |
| Pubmed | TPR DDX17 DHX40 SPTBN1 APC THOC2 TRIM59 EFTUD2 LMNB1 WDR11 DOCK7 USP39 ALPK2 ATP5F1B | 3.77e-06 | 809 | 136 | 14 | 32129710 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.45e-06 | 497 | 136 | 11 | 36774506 | |
| Pubmed | Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates. | 4.83e-06 | 9 | 136 | 3 | 34107259 | |
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 9278515 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TPR SATB2 DDX17 SPTBN1 MCM7 EFTUD2 LMNB1 UBTF ZFR CDC73 USP39 ATP5F1B | 4.93e-06 | 605 | 136 | 12 | 28977666 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | CUL4B DDX17 DHX40 SYNE1 PPIL4 MCM7 EFTUD2 CRNKL1 LMNB1 TJP2 ZFR USP39 ATP5F1B | 4.95e-06 | 714 | 136 | 13 | 28302793 |
| Pubmed | TPR SATB2 DDX17 DHX40 SPTBN1 PPIL4 CRNKL1 RIF1 DOCK7 ZFR ATP5F1B | 5.27e-06 | 506 | 136 | 11 | 30890647 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4B TPR DDX17 PPIL4 THOC2 EFTUD2 CRNKL1 RIF1 LMNB1 UBTF ZFR CDC73 KIF18B TASOR ATP5F1B | 5.31e-06 | 954 | 136 | 15 | 36373674 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX17 FBLL1 VWA8 SYNE1 SPTBN1 HECTD4 PPIL4 APC THOC2 EFTUD2 CRNKL1 NWD2 LMNB1 DOCK7 CHD6 USP39 | 5.48e-06 | 1082 | 136 | 16 | 38697112 |
| Pubmed | TPR DDX17 FBLL1 PLEKHS1 THOC2 EFTUD2 CRNKL1 RIF1 UBTF TJP2 ZFR USP39 TASOR ATP5F1B | 6.35e-06 | 847 | 136 | 14 | 35850772 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MTMR12 TRIO SPTBN1 APC TSC2 BRCC3 MICALL1 TTLL12 SLC12A2 XRN1 DOCK7 TJP2 TP53BP2 ARAP2 | 7.64e-06 | 861 | 136 | 14 | 36931259 |
| Pubmed | 7.85e-06 | 255 | 136 | 8 | 15324660 | ||
| Pubmed | 8.08e-06 | 339 | 136 | 9 | 30415952 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR DDX17 SPTBN1 PPIL4 MCM7 THOC2 SQOR EFTUD2 CRNKL1 LMNB1 WDR11 UBTF DOCK7 TJP2 ZFR USP39 ATP5F1B | 8.83e-06 | 1257 | 136 | 17 | 36526897 |
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 27760310 | ||
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 32973045 | ||
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 26403076 | ||
| Pubmed | Proteotyping of knockout mouse strains reveals sex- and strain-specific signatures in blood plasma. | 9.47e-06 | 34 | 136 | 4 | 34050187 | |
| Pubmed | CDC42BPG MTMR12 DHX40 APC GRB7 ZDHHC17 CEMIP2 TTLL12 WDR11 XRN1 DOCK7 TASOR | 1.01e-05 | 650 | 136 | 12 | 38777146 | |
| Pubmed | CUL4B TPR SPTBN1 THOC2 TTLL12 CRNKL1 RIF1 UBTF XRN1 DOCK7 TJP2 ZFR | 1.06e-05 | 653 | 136 | 12 | 22586326 | |
| Pubmed | TPR DDX17 SPTBN1 PPIL4 EFTUD2 CRNKL1 RIF1 ZFR CDC73 TASOR ATP5F1B | 1.17e-05 | 551 | 136 | 11 | 34728620 | |
| Pubmed | Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. | 1.25e-05 | 12 | 136 | 3 | 19150975 | |
| Pubmed | DDX17 ANK3 TRIO SYNE1 SPTBN1 APC PLEKHA6 RTN1 ALG2 NWD2 EHD1 XRN1 DOCK7 PLXNA4 TJP2 MAPK1 TP53BP2 ATP5F1B | 1.26e-05 | 1431 | 136 | 18 | 37142655 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ANK3 SPTBN1 PLEKHA6 STAT2 CEMIP2 MICALL1 SLC12A2 EHD1 XRN1 TJP2 TP53BP2 | 1.48e-05 | 565 | 136 | 11 | 25468996 |
| Pubmed | 1.49e-05 | 38 | 136 | 4 | 32541003 | ||
| Pubmed | Novel functions for the endocytic regulatory proteins MICAL-L1 and EHD1 in mitosis. | 1.52e-05 | 2 | 136 | 2 | 25287187 | |
| Pubmed | TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway. | 1.52e-05 | 2 | 136 | 2 | 32744597 | |
| Pubmed | Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cells. | 1.52e-05 | 2 | 136 | 2 | 25228656 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32380568 | ||
| Pubmed | STAT2 Controls Colorectal Tumorigenesis and Resistance to Anti-Cancer Drugs. | 1.52e-05 | 2 | 136 | 2 | 38001683 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 30258099 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19889999 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 14764702 | ||
| Pubmed | Genetic Analysis Reveals the Important Role of the APC Gene in Clear Cell Renal Cell Carcinoma. | 1.52e-05 | 2 | 136 | 2 | 34475049 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24138531 | ||
| Pubmed | Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. | 1.52e-05 | 2 | 136 | 2 | 10892652 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 1.52e-05 | 2 | 136 | 2 | 8026587 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17074766 | ||
| Pubmed | OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis. | 1.52e-05 | 2 | 136 | 2 | 20844189 | |
| Pubmed | NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and strengthening. | 1.52e-05 | 2 | 136 | 2 | 29278843 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17954272 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15364545 | ||
| Pubmed | Reversal of memory and autism-related phenotypes in Tsc2+/- mice via inhibition of Nlgn1. | 1.52e-05 | 2 | 136 | 2 | 37293130 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22246186 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 37064897 | ||
| Pubmed | Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APCmin+/- mice. | 1.52e-05 | 2 | 136 | 2 | 39055928 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 38761506 | ||
| Pubmed | MICAL-L1 coordinates ciliogenesis by recruiting EHD1 to the primary cilium. | 1.52e-05 | 2 | 136 | 2 | 31615969 | |
| Pubmed | Paradoxical dampening of anti-islet self-reactivity but promotion of diabetes by OX40 ligand. | 1.52e-05 | 2 | 136 | 2 | 14662903 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | CTDSP1 PLEKHA6 ITGB6 CEMIP2 MICALL1 NLGN4X SLC12A2 ARHGAP31 EHD1 DOCK7 ARAP2 | 1.58e-05 | 569 | 136 | 11 | 30639242 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.58e-05 | 281 | 136 | 8 | 28706196 | |
| Pubmed | GIGYF1 disruption associates with autism and impaired IGF-1R signaling. | 1.63e-05 | 13 | 136 | 3 | 35917186 | |
| Pubmed | 1.63e-05 | 13 | 136 | 3 | 25698753 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.67e-05 | 283 | 136 | 8 | 30585729 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ANK3 SPTBN1 CTDSP1 CEMIP2 MICALL1 SLC12A2 ARHGAP31 EHD1 DOCK7 | 1.88e-05 | 377 | 136 | 9 | 38117590 |
| Pubmed | TPR ANK3 SPTBN1 APC ZDHHC17 TEC THOC2 TTC3 TRIM59 UBTF TJP2 TAOK1 MAPK1 TASOR TRIM37 | 2.38e-05 | 1084 | 136 | 15 | 11544199 | |
| Pubmed | 2.57e-05 | 15 | 136 | 3 | 18227507 | ||
| Pubmed | 2.57e-05 | 15 | 136 | 3 | 22723706 | ||
| Pubmed | 2.57e-05 | 15 | 136 | 3 | 33116259 | ||
| Pubmed | 2.57e-05 | 15 | 136 | 3 | 36028553 | ||
| Pubmed | 3.11e-05 | 225 | 136 | 7 | 25277244 | ||
| Pubmed | CUL4B TRIO APC RTN1 STAT2 CEMIP2 SLC12A2 BBS7 XRN1 TJP2 CHD6 TASOR | 3.30e-05 | 733 | 136 | 12 | 34672954 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | ANKRD35 DDR1 RGS19 GRB7 TSC2 TTC3 EFTUD2 CRNKL1 UFD1 TBC1D14 DOCK7 TAOK1 CDC73 TP53BP2 ATP5F1B | 3.60e-05 | 1124 | 136 | 15 | 21900206 |
| Pubmed | An NAD+-Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39. | 3.82e-05 | 17 | 136 | 3 | 32711345 | |
| Pubmed | Fstl1 is involved in the regulation of radial glial scaffold development. | 3.82e-05 | 17 | 136 | 3 | 26382033 | |
| Pubmed | 4.27e-05 | 419 | 136 | 9 | 15635413 | ||
| Pubmed | Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. | 4.54e-05 | 3 | 136 | 2 | 17620337 | |
| Pubmed | Developmental expression and subcellular distribution of synaptotagmin 11 in rat hippocampus. | 4.54e-05 | 3 | 136 | 2 | 22960622 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 28607166 | ||
| Interaction | TNIK interactions | TPR ANK3 TRIO SYNE1 SPTBN1 APC EFTUD2 LMNB1 DOCK7 NLGN2 CDC73 MAPK1 EPHA5 | 1.36e-06 | 381 | 132 | 13 | int:TNIK |
| Interaction | AR interactions | CUL4B VHL TPR CDC42BPG SIN3B DDX17 HECTD4 GRB7 MCM7 EFTUD2 TTLL12 CRNKL1 FOXP4 LMNB1 UBTF PSMC3IP ZFR CDC73 PAX6 MAPK1 ATP5F1B | 1.90e-06 | 992 | 132 | 21 | int:AR |
| Interaction | CHEK2 interactions | 5.98e-06 | 250 | 132 | 10 | int:CHEK2 | |
| Interaction | PHF21A interactions | 1.64e-05 | 343 | 132 | 11 | int:PHF21A | |
| Interaction | CIT interactions | TPR ANKRD35 RAG1 DDX17 FBLL1 VWA8 SYNE1 SPTBN1 PPIL4 MCM7 PLEKHA6 THOC2 TTC3 SQOR EFTUD2 CRNKL1 RIF1 LMNB1 UBTF TJP2 ZFR CDC73 USP39 ATP5F1B | 2.18e-05 | 1450 | 132 | 24 | int:CIT |
| Interaction | ZNF785 interactions | 3.80e-05 | 95 | 132 | 6 | int:ZNF785 | |
| Interaction | KDF1 interactions | 3.94e-05 | 192 | 132 | 8 | int:KDF1 | |
| Interaction | DLG4 interactions | FBLL1 HTR2C ANK3 SYNE1 SPTBN1 NLGN1 ZDHHC17 NLGN4X PYGM NLGN2 MAPK1 PCDH10 | 4.04e-05 | 449 | 132 | 12 | int:DLG4 |
| Interaction | CDC5L interactions | TPR DDX17 TRIO DHX40 SYNE1 SPTBN1 MAGEE2 THOC2 EFTUD2 CRNKL1 RIF1 FOXP4 UBTF EHD1 CDC73 USP39 TP53BP2 | 4.40e-05 | 855 | 132 | 17 | int:CDC5L |
| Interaction | ZYX interactions | 6.30e-05 | 329 | 132 | 10 | int:ZYX | |
| Interaction | TXNIP interactions | 7.93e-05 | 212 | 132 | 8 | int:TXNIP | |
| Interaction | CAV1 interactions | HTR2C ANK3 TRIO SPTBN1 APC GRB7 TSC2 CEMIP2 MICALL1 TTLL12 SLC12A2 UFD1 EHD1 MAPK1 TRIM37 | 8.10e-05 | 724 | 132 | 15 | int:CAV1 |
| Cytoband | 1q25 | 6.29e-05 | 26 | 136 | 3 | 1q25 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.14e-04 | 206 | 96 | 7 | 682 | |
| GeneFamily | Cytochrome P450 family 4 | 9.12e-04 | 36 | 96 | 3 | 1003 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | FBLL1 ANK3 FAT3 PLEKHA6 RTN1 TTLL7 ULK3 PPP2R3A NLGN4X GLCE PLXNA4 PAPPA EPHA5 | 2.28e-06 | 506 | 135 | 13 | M39067 |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP | 2.45e-06 | 166 | 135 | 8 | M9015 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | VHL DDR1 SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 ALG2 STAT2 ULK3 RSPH3 BBS7 CHD6 PCDH10 EPHA5 | 1.39e-07 | 721 | 134 | 19 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | VHL DDR1 SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 ALG2 STAT2 ULK3 RSPH3 BBS7 CHD6 PCDH10 EPHA5 | 1.69e-07 | 730 | 134 | 19 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | VHL DDR1 SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 ULK3 RSPH3 CDH20 BBS7 CHD6 PAX6 PCDH10 EPHA5 | 2.40e-07 | 747 | 134 | 19 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | VHL DDR1 SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 ALG2 ULK3 RSPH3 BBS7 CHD6 PCDH10 EPHA5 | 6.86e-07 | 722 | 134 | 18 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | VHL DDR1 SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 ALG2 RSPH3 BBS7 CHD6 PAX6 PCDH10 EPHA5 | 1.03e-06 | 743 | 134 | 18 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 ALG2 ULK3 RSPH3 BBS7 CHD6 PAX6 PCDH10 EPHA5 | 4.88e-06 | 747 | 134 | 17 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | DDR1 SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 RSPH3 BBS7 CHD6 PAX6 PCDH10 EPHA5 | 1.56e-05 | 732 | 134 | 16 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | DDR1 SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 RSPH3 BBS7 CHD6 PCDH10 EPHA5 | 1.80e-05 | 658 | 134 | 15 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 CEMIP2 RSPH3 BBS7 CHD6 PCDH10 EPHA5 | 1.83e-05 | 659 | 134 | 15 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.96e-05 | 249 | 134 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SLC36A4 VWA8 FAT3 HECTD4 PPIL4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 RSPH3 BBS7 CHD6 PCDH10 EPHA5 | 3.02e-05 | 688 | 134 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | TRIO ADAMTS2 FAT3 SPTBN1 ANO1 THOC2 RIF1 SLC12A2 NALCN ADAMTS9 ARHGAP31 UBTF ZFR TAOK1 MAPK1 PCDH10 | 3.93e-05 | 790 | 134 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 5.66e-05 | 65 | 134 | 5 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SLC36A4 VWA8 FAT3 HECTD4 ANO1 MAGEE2 MDGA2 NLGN1 RTN1 RSPH3 BBS7 PCDH10 EPHA5 | 1.40e-04 | 614 | 134 | 13 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPR ANK3 TRIO FAT3 APC REV3L RTN1 SLC12A2 LMNB1 ADAMDEC1 TBC1D14 TAOK1 PCDH10 ARAP2 EPHA5 | 1.76e-04 | 806 | 134 | 15 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 2.36e-04 | 194 | 134 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.45e-04 | 138 | 134 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 2.70e-04 | 408 | 134 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 2.94e-04 | 92 | 134 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.98e-04 | 151 | 134 | 6 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.02e-04 | 279 | 134 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.85e-07 | 199 | 136 | 8 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 1.92e-07 | 200 | 136 | 8 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 1.92e-07 | 200 | 136 | 8 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-07 | 164 | 136 | 7 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-07 | 170 | 136 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 175 | 136 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-06 | 186 | 136 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.78e-06 | 187 | 136 | 7 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 2.78e-06 | 200 | 136 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 2.78e-06 | 200 | 136 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.24e-06 | 155 | 136 | 6 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-06 | 155 | 136 | 6 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 169 | 136 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 177 | 136 | 6 | 8c78f7de091f16e86e326a73c9f1429e0232821f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 178 | 136 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.81e-05 | 178 | 136 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-05 | 180 | 136 | 6 | 5e6e38ee0758ef2342a6a821c78ed24b57bb7b11 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.93e-05 | 180 | 136 | 6 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-05 | 180 | 136 | 6 | b88cd7ae922782176c057342d1b9eb9b8e5e7204 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-05 | 180 | 136 | 6 | ebd6e719a03f25155fa8181be19469d04d6d10a6 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 182 | 136 | 6 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 182 | 136 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 182 | 136 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.05e-05 | 182 | 136 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.12e-05 | 183 | 136 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.18e-05 | 184 | 136 | 6 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.25e-05 | 185 | 136 | 6 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 185 | 136 | 6 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.25e-05 | 185 | 136 | 6 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.32e-05 | 186 | 136 | 6 | cf96f880e6e22189593ce1357c55e65c34644559 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 186 | 136 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.39e-05 | 187 | 136 | 6 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 187 | 136 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 188 | 136 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 188 | 136 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 190 | 136 | 6 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 190 | 136 | 6 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.61e-05 | 190 | 136 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-05 | 191 | 136 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.69e-05 | 191 | 136 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.77e-05 | 192 | 136 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.77e-05 | 192 | 136 | 6 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 193 | 136 | 6 | 4a1b4a2faf741ffba5c84218af4df6a8b2a9f4de | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial-type_II_pneumocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 193 | 136 | 6 | 68adc680deb2f1a29d3cca19c13b9f6271dd4d60 | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 193 | 136 | 6 | 819e6ee2ffa3e31bf9a2d57c99d9e3eac7072765 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 195 | 136 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 195 | 136 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 196 | 136 | 6 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 196 | 136 | 6 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_PFC-23|World / Primary Cells by Cluster | 3.20e-05 | 197 | 136 | 6 | def63e7e28dd398722e528b7816a34de92552419 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_PFC|World / Primary Cells by Cluster | 3.20e-05 | 197 | 136 | 6 | 26fd54acd90292a01ef0d892ba16ccdade987f36 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.29e-05 | 198 | 136 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 3.39e-05 | 199 | 136 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 3.39e-05 | 199 | 136 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 3.39e-05 | 199 | 136 | 6 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 3.39e-05 | 199 | 136 | 6 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.39e-05 | 199 | 136 | 6 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-05 | 200 | 136 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.48e-05 | 200 | 136 | 6 | c082bc21ec7c5323439d108ea8aea510e1113c3f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-05 | 200 | 136 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-05 | 200 | 136 | 6 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-05 | 125 | 136 | 5 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.27e-05 | 70 | 136 | 4 | 2121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.27e-05 | 70 | 136 | 4 | cd6bca68fe52f451716fc8c0b1745984bc9ec057 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.27e-05 | 70 | 136 | 4 | be300c0447735aba89df4c3082b81eb5abf22770 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.54e-05 | 142 | 136 | 5 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.79e-05 | 143 | 136 | 5 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 144 | 136 | 5 | 1d05aa08603cba28c0c6511767e434c1f592a3aa | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 144 | 136 | 5 | d3f6f5da56794367ee3776bfd3a9dcf893efe0f0 | |
| ToppCell | Serous|World / shred by cell class for turbinate | 9.76e-05 | 150 | 136 | 5 | 6a326662d58b0f17d6efa8cc28571f4cbbf57c2d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-04 | 165 | 136 | 5 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-04 | 167 | 136 | 5 | 5accd0bc7c95089feb2c09376d12cd8bd3773775 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 168 | 136 | 5 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 1.66e-04 | 168 | 136 | 5 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 169 | 136 | 5 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 136 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | Ionocyte|World / Class top | 1.75e-04 | 170 | 136 | 5 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 172 | 136 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-04 | 172 | 136 | 5 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 172 | 136 | 5 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 172 | 136 | 5 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 172 | 136 | 5 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 1.90e-04 | 173 | 136 | 5 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.95e-04 | 174 | 136 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.01e-04 | 175 | 136 | 5 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 175 | 136 | 5 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 175 | 136 | 5 | 97a58bc6ed2e8e359283d4214172c990c6e3755e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 175 | 136 | 5 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.01e-04 | 175 | 136 | 5 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.06e-04 | 176 | 136 | 5 | 9a4cef3dc88f64a71b91ab4790ea19334afee3ee | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.28e-05 | 50 | 80 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | phenethyl isothiocyanate | TPR PPIL4 MCM7 THOC2 RSPH3 SLC12A2 LMNB1 GCLC UBTF PAPPA MAPK1 KIF18B ATP5F1B | 7.46e-07 | 401 | 134 | 13 | ctd:C058305 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.96e-07 | 152 | 134 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | autosomal recessive intellectual developmental disorder (is_implicated_in) | 2.05e-05 | 2 | 134 | 2 | DOID:0060308 (is_implicated_in) | |
| Disease | Schizophrenia | DDR1 HTR2C ANK3 APC NLGN1 PLEKHA6 SLC12A2 WDR11 GCLC UFD1 NLGN2 TRPM1 PAX6 MAPK1 | 5.14e-05 | 883 | 134 | 14 | C0036341 |
| Disease | unipolar depression, bipolar disorder | 8.15e-05 | 156 | 134 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.22e-04 | 4 | 134 | 2 | EFO_0020830 | |
| Disease | Autistic Disorder | 1.98e-04 | 261 | 134 | 7 | C0004352 | |
| Disease | Lung Neoplasms | 2.17e-04 | 265 | 134 | 7 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.22e-04 | 266 | 134 | 7 | C0242379 | |
| Disease | level of Phosphatidylcholine (18:2_18:2) in blood serum | 3.03e-04 | 6 | 134 | 2 | OBA_2045106 | |
| Disease | longitudinal BMI measurement, response to amisulpride | 3.07e-04 | 29 | 134 | 3 | EFO_0005937, EFO_0010718 | |
| Disease | bipolar disorder (is_implicated_in) | 3.07e-04 | 29 | 134 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | alcohol drinking | 5.16e-04 | 81 | 134 | 4 | EFO_0004329 | |
| Disease | cataract (implicated_via_orthology) | 6.88e-04 | 38 | 134 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | velocardiofacial syndrome (implicated_via_orthology) | 7.22e-04 | 9 | 134 | 2 | DOID:12583 (implicated_via_orthology) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 7.22e-04 | 9 | 134 | 2 | EFO_0800562 | |
| Disease | Craniofacial Abnormalities | 7.48e-04 | 156 | 134 | 5 | C0376634 | |
| Disease | Kidney Neoplasm | 8.00e-04 | 40 | 134 | 3 | C0022665 | |
| Disease | medulloblastoma (is_implicated_in) | 8.99e-04 | 10 | 134 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Myocardial Infarction | 9.40e-04 | 95 | 134 | 4 | C0027051 | |
| Disease | myocardial infarction (is_implicated_in) | 1.10e-03 | 99 | 134 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | Malignant neoplasm of kidney | 1.13e-03 | 45 | 134 | 3 | C0740457 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.31e-03 | 12 | 134 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Parkinson's disease symptom measurement | 1.36e-03 | 48 | 134 | 3 | EFO_0600011 | |
| Disease | – | 1.55e-03 | 13 | 134 | 2 | 608446 | |
| Disease | Myocardial infarction, susceptibility to | 1.55e-03 | 13 | 134 | 2 | cv:C1832662 | |
| Disease | pulmonary emphysema (implicated_via_orthology) | 1.55e-03 | 13 | 134 | 2 | DOID:9675 (implicated_via_orthology) | |
| Disease | fibrinogen measurement | 1.57e-03 | 109 | 134 | 4 | EFO_0004623 | |
| Disease | macula measurement | 1.75e-03 | 189 | 134 | 5 | EFO_0008375 | |
| Disease | phosphatidylcholine measurement | 1.94e-03 | 284 | 134 | 6 | EFO_0010226 | |
| Disease | Prostatic Neoplasms | 2.06e-03 | 616 | 134 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.06e-03 | 616 | 134 | 9 | C0376358 | |
| Disease | Carcinoma of Endocrine Gland | 2.07e-03 | 15 | 134 | 2 | C1704374 | |
| Disease | employment status | 2.07e-03 | 15 | 134 | 2 | EFO_0005241 | |
| Disease | alkaline phosphatase measurement | ADAMTS2 MOGAT2 TRIM41 SPTBN1 TSC2 NWD2 C1QTNF1 NLGN2 RP1 STKLD1 ALPK2 PMFBP1 | 2.33e-03 | 1015 | 134 | 12 | EFO_0004533 |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.59e-03 | 301 | 134 | 6 | DOID:684 (is_marker_for) | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.66e-03 | 17 | 134 | 2 | C0751883 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.72e-03 | 61 | 134 | 3 | DOID:3587 (is_marker_for) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.72e-03 | 61 | 134 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | Disorder of eye | 2.88e-03 | 212 | 134 | 5 | C0015397 | |
| Disease | cystathionine measurement | 3.33e-03 | 19 | 134 | 2 | EFO_0010474 | |
| Disease | diet measurement, HOMA-B | 3.33e-03 | 19 | 134 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.55e-03 | 67 | 134 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 3.69e-03 | 20 | 134 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | skin pigmentation | 3.86e-03 | 69 | 134 | 3 | EFO_0003784 | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.86e-03 | 69 | 134 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | disease | 4.06e-03 | 21 | 134 | 2 | EFO_0000408 | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.46e-03 | 22 | 134 | 2 | DOID:2030 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| INHDVVEPLYIEVDQ | 141 | Q8NBZ7 | |
| EIQEHYPEEFALRDQ | 341 | P16118 | |
| EEADHLQEEYKKQPA | 651 | Q8IWZ6 | |
| FHLKYDEVRLDPNVQ | 476 | Q6P1J9 | |
| RANQIDEKEHPYKEE | 136 | Q86TB3 | |
| PKEEEYLQVDLQRLH | 81 | Q08345 | |
| YEDPNQAVHEFAKEI | 656 | P54756 | |
| YRHTNEPVIEKASDN | 416 | P28335 | |
| PHIEVYETAEDRDKN | 231 | O94923 | |
| EIYNHILQTVVPDED | 621 | Q4L235 | |
| ENEELERPLHYKENV | 1381 | Q8WZ64 | |
| KIQYEVHGRSQPEEQ | 411 | Q8N283 | |
| EIQNPYLHVEPEKEV | 786 | Q13625 | |
| VDEPYKIHGLEDEVQ | 1161 | O95450 | |
| EHYDVARGVQKILQD | 416 | P06576 | |
| HEEDNYIELIPRDRK | 561 | Q9ULI1 | |
| NPYHESVEELRDRVK | 766 | P15918 | |
| YVHRDVKPDNVLLDV | 191 | Q6DT37 | |
| KDFVPYQDIRINHTV | 146 | Q8WUA2 | |
| VTEHPLDREVRNEYN | 351 | Q96TA0 | |
| QIEALEKEFERTHYP | 221 | P26367 | |
| RIEVEQALAHPYLEQ | 301 | P28482 | |
| VNVVVEEDKPHYGLR | 76 | Q8WUE5 | |
| HIYLLVQQPESEEEQ | 376 | Q8TD90 | |
| TNHVTPEEKEQVYRE | 151 | Q9P2W1 | |
| VSYVRPEEIHTNEKE | 21 | Q9C0I1 | |
| EQHDAQVRLYKEELE | 251 | P20700 | |
| QEQLTLEPYERDHAV | 306 | A6NHQ2 | |
| AKIHQDLVFQYVEDP | 1026 | Q9HCM2 | |
| LQVHVRQTEDYPVDL | 121 | P18564 | |
| QVYVLKRPHVDEFLQ | 126 | Q9GZU7 | |
| HVEQLVESVFKNYDP | 466 | Q8TDF6 | |
| DKEIYEQLLQEGIDH | 351 | P48506 | |
| EIPYLQKEAINFRHD | 221 | A1E959 | |
| VRKHQQGIYSIDEDE | 16 | Q6ZMV9 | |
| RKVQADQYIPEEDIH | 671 | Q8N3F8 | |
| YSHQVQVKEEPAEAE | 631 | Q8IVH2 | |
| PDHEECVKRKQRYEV | 701 | Q5XXA6 | |
| ELVDQDIQPARYHIA | 381 | Q8N2Q7 | |
| RVVNLYEDDHKNPTV | 356 | Q13219 | |
| YEDDHKNPTVTREQV | 361 | Q13219 | |
| EKPLDREQQAVHRYV | 186 | Q9P2E7 | |
| DDDIPQEDHYALLVK | 2241 | Q9Y4D8 | |
| QEVYNEQIHDLLEPK | 156 | Q86Y91 | |
| ELQIEIIADYEVHPN | 96 | Q9Y4U1 | |
| YLDHEQRDPFAVQKD | 1061 | Q06190 | |
| SKDPRHLQYVADVNE | 266 | Q14451 | |
| DPYHKDDNIQIGREV | 341 | Q7Z553 | |
| REVVNKDVLDVYIEH | 91 | P33993 | |
| DVNDEAPVFKQHLYE | 1716 | Q6V1P9 | |
| TAEDKEIQRINEHPY | 3101 | Q6V1P9 | |
| PSEEEVNQLHQRYIK | 296 | Q3SYC2 | |
| TVPQDQRRDEEKIYH | 431 | P0DPD8 | |
| DEEEQNKPHIIYRRS | 196 | Q9P2N4 | |
| RRFQYEEEVKANPHN | 476 | Q9BZJ0 | |
| ERAEEQHEKYRPSQD | 51 | Q9BXJ1 | |
| EVYKVLIPIHEANRD | 1796 | Q96N67 | |
| NPDYVEVDRILEVAH | 371 | Q8TD26 | |
| RKQPYIIDDEENIHE | 646 | Q9HBT6 | |
| KHPEYQEQCRQEVQE | 346 | Q9HBI6 | |
| RVIVNVEDANDHSPY | 1551 | Q8TDW7 | |
| LQDEHDKYQLAEPVI | 3286 | Q12955 | |
| YEPVHSLEELQRKQS | 1101 | Q9UHN6 | |
| KHPEYQERCRQEVQE | 346 | P78329 | |
| KHPEYQERCRQEVQE | 346 | Q08477 | |
| EKNFYVEHPEVARLT | 131 | Q92841 | |
| RPVDPEYQKEAEQRH | 526 | Q8IX18 | |
| GEIYQKIEREHQISP | 336 | Q9H4M9 | |
| VPFNLITEYHREEEK | 441 | Q9UMX9 | |
| ELVDQDVQPARYHIA | 336 | Q8NFZ4 | |
| IYVPTEDDIHDQNSK | 151 | Q8N0W4 | |
| QEREVPEYLHHVNKR | 406 | Q13620 | |
| ERASTPYIEKQVDHL | 61 | Q969Z0 | |
| VEEGEKEFHVRNPQV | 171 | Q99487 | |
| HPYLLQTDKNVFREE | 1956 | P56715 | |
| HVEEYQNLVKDLRVE | 321 | Q8TBY8 | |
| YIDITRPEEVKHQEQ | 196 | Q16799 | |
| NFEQPYEKHAEILQE | 596 | Q5TCS8 | |
| NQHVVDEKARLIYED | 131 | P49795 | |
| VDVDKETLQHRRYPN | 316 | Q9Y6N5 | |
| PLAEIYEQHVTKVNE | 131 | O94972 | |
| KQHSVVPLEEVVQEY | 256 | Q8WV44 | |
| EHQDDDKVLIYSVQP | 616 | P52630 | |
| PAEEKEQLLHNDEYQ | 366 | Q53GS9 | |
| EEIHCYEPQLNRLKE | 3221 | Q8NF91 | |
| ERGQEYLILEKNDVH | 201 | P42680 | |
| YHEQQVKTRGLEEIP | 2361 | Q5UIP0 | |
| REQYEEEQEVKAELH | 1356 | Q9Y2K3 | |
| NLPQHERDVIYEEES | 546 | Q9UPW6 | |
| AQTEDPVEVQHLARY | 976 | O75182 | |
| VIHLKPEEENYREEG | 396 | Q7L7X3 | |
| HKDVAEEIANYRPTL | 786 | Q01082 | |
| EELRQKHEYELNSTP | 806 | Q9UK61 | |
| QHISIEGQKEEERYE | 196 | P46736 | |
| NQTEKHGKEERYEPE | 61 | O15204 | |
| DERVLENVEHYQELK | 271 | Q9H553 | |
| EQHEEEERPTNYSIK | 1151 | P25054 | |
| KPAEEAQKHRQQYEE | 326 | Q9P2M4 | |
| QDVKEENHYLTPRSV | 201 | Q5SXH7 | |
| RKMELEPQHYDVDIN | 901 | Q9Y2H5 | |
| EPQHYDVDINKELST | 906 | Q9Y2H5 | |
| IRKPDAYTEQLHNEE | 116 | Q9P0T7 | |
| PVEGRKHVDVQTELY | 246 | Q86UC2 | |
| ARIEIAQKHPDIYAV | 1106 | Q9UDY2 | |
| QEVNISLHYQKDEEP | 111 | P23510 | |
| DLAVPHTSYEREVNK | 891 | Q8NI27 | |
| EREYKVHINPNSLFD | 551 | P11217 | |
| FHEIANIIKRYDPDI | 2386 | O60673 | |
| YQLHRDDPEVVENVG | 601 | Q8NE28 | |
| HLVSQQKDPDTEEYR | 1341 | P12270 | |
| QQAVIYEREPVAERH | 36 | Q8N4C7 | |
| KYNELRQHEITDGEI | 76 | Q86TD4 | |
| QEYKPDTHQELFLQE | 296 | Q86TD4 | |
| EIIEPYRLHEDDKEQ | 1106 | P55011 | |
| VRSLYEDLEDHPNVQ | 181 | P40337 | |
| VKEHQIPEFDNLYLD | 21 | Q8IZH2 | |
| SEAENQFKRIIEHYP | 556 | P53804 | |
| RVYSQDPQDLDIVAH | 1156 | Q2M1Z3 | |
| NYDPDVVLKQVHCEE | 516 | Q14166 | |
| YDVRQPDKENVTLLH | 81 | Q8IUH5 | |
| PYIVSEAAVQAEHKE | 1486 | Q7Z4N2 | |
| EQLAQYLLAEEPHVE | 131 | Q8N7F7 | |
| GYKEPERQVQHEEST | 196 | Q92890 | |
| VQPVGHDYVEEVRND | 561 | Q96KR1 | |
| PDHVEVETAREGKQY | 796 | Q86YA3 | |
| DEQFILDRHPKYDNI | 326 | Q9P0Z9 | |
| RDYIQKHPELNISEE | 261 | P17480 | |
| EQTHPEIRKRYDQDL | 151 | Q15029 | |
| DISHVDYPENEEIKN | 871 | Q9BZH6 | |
| NIQEYPIERHEERSL | 1081 | A3KMH1 | |
| QEPERKFLEEEQQLH | 1511 | Q07283 | |
| EQELLPVQKHYQLDD | 41 | Q6YBV0 | |
| KTVPQELFRDYHELE | 181 | A8MT65 | |
| AIIEKYQQEDHPDIV | 81 | Q8IWR1 | |
| SQDHLIVQEYIEKPF | 181 | Q6ZT98 | |
| DPEEIYQAAHQLEDR | 641 | O75962 | |
| VIKDYPSNEDLHERL | 126 | P49815 | |
| PALHYEVDAQRKEAI | 316 | Q6PHR2 | |
| VQEEELRENHPYFDK | 821 | Q8IZF0 |